News

Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up customer demand although some ...
GLP-1 stands for glucagon-like peptide-1, a satiety hormone the body produces when we eat to help stimulate digestion and ...
The FDA has been cut off from producing compounded weight-loss drugs such as Ozempic, Mounjaro or Wegovy, the most effective ...
Novo Nordisk's Q1 showed robust sales/EPS growth, fueled by soaring GLP-1 demand in a multi-billion dollar market. Read why I ...
Discover how compounding pharmacies are transforming healthcare by creating tailor-made medications for patients with unique needs, offering critical alternatives when standard drugs fall short ...
(Reuters) -After years of easily available, cheap copies of Eli Lilly's and Novo Nordisk's highly effective weight-loss drugs ...
Eli Lilly & Co. will only work with telehealth firms that agree to stop selling copycat versions of weight-loss drugs, diminishing the likelihood of a partnership with one most visible players in the ...
Are you weening yourself off a compounded version of the drug? Considering switching insurers in order to keep your ...
As the Food and Drug Administration clamps down on off-brand weight loss medications, Seattle-area residents are stocking up ...
Outro, which is now available in seven states, wants to help people taper off antidepressants without experiencing ...
US telehealth group explores selling ‘compounded medications’ in new markets after buying London-based rival Zava ...
Otherwise, this looks like a fantastic growth stock that just doubled its addressable market with the Zava acquisition. Today ...